M&A Deal Summary |
|
---|---|
Date | 2015-10-20 |
Target | Topical Apothecary Group |
Sector | Life Science |
Buyer(s) | Harrow |
Sellers(s) | Thousand Oaks Holding |
Deal Type | Divestiture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1998 |
Sector | Life Science |
Employees | 315 |
Revenue | 130M USD (2023) |
Harrow is a developer, producer, and dispenser of novel compounded pharmaceuticals. The company's business primarily consists of four therapeutic segments including ophthalmology, urology, sinus and integrative medicine. Harrow was founded in 1998 and is based in Nashville, California.
DEAL STATS | # |
---|---|
Overall | 6 of 8 |
Sector (Life Science) | 4 of 6 |
Type (Divestiture) | 4 of 6 |
State (Pennsylvania) | 1 of 1 |
Country (United States) | 6 of 7 |
Year (2015) | 4 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-10-20 |
Mycotoxins
United States Mycotoxins LLC is a pharmaceutical company. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-07-27 |
Sintetica - Patented Ophthalmic Surgical Drug Candidate
United States Sintetica's Patented Ophthalmic Surgical Drug Candidate provides ocular surface anesthesia during ophthalmic interventions such as cataract surgery and intravitreal injections. |
Buy | - |
Thousand Oaks Holding Co. is a pharmaceutical company.
DEAL STATS | # |
---|---|
Overall | 4 of 4 |
Sector (Life Science) | 3 of 3 |
Type (Divestiture) | 4 of 4 |
State (Pennsylvania) | 1 of 1 |
Country (United States) | 4 of 4 |
Year (2015) | 4 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-10-20 |
Mycotoxins
United States Mycotoxins LLC is a pharmaceutical company. |
Sell | - |